Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RePo1: Revatio in Portopulmonary Hypertension
NCT01517854Phase 2Terminated
- Sponsor
- University Health Network
- Start
- Nov 2012
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in portopulmonary hypertension (POPH), sponsored by University Health Network. Started Nov 2012; status: terminated.
02
Drugs
sildenafil
03
Conditions
portopulmonary hypertension (POPH)
Beyond the preview
Go deeper on NCT01517854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01517854.